Syndrome of hypokalemic metabolic alkalosis and hypomagnesemia associated with gentamicin therapy: Case reports

Clinical Pediatrics

Volumn 39, Issue 9, 2000, Pages 529-533

  Shetty, A K ^a   Rogers, N L ^a   Mannick, E E ^a   Aviles, D H ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM; GENTAMICIN; MAGNESIUM; METICILLIN; POTASSIUM; VANCOMYCIN;

ADULT; ARTICLE; BRAIN ABSCESS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPOKALEMIC ALKALOSIS; HYPOMAGNESEMIA; INFANT; KIDNEY TUBULE FUNCTION; MALE; NEPHROTOXICITY; TREATMENT OUTCOME; WOUND INFECTION;

EID: 0033827134     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280003900904     Document Type: Article

References (30)

1. Hyperplasia of the juxta-glomerular complex with hyperaldosteronism and hypokalemic alkalosis
2. Evidence for a prostaglandin independent defect in chloride reabsorption in loop of Henle as a proximal cause of Bartter's syndrome
3. Bartter's syndrome, hypokalemic metabolic alkalosis, is caused by mutations in the Na-K-2Cl cotransporter NKCC2
4. Gitelman's variant of Bartter syndrome, inherited hypokalemic metabolic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter
5. Mutations encoding the inwardly rectifying renal potassium channel, ROMK, cause antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity
6. Surreptitious diuretic ingestion and pseudo-Bartter's syndrome
7. Indomethacin and atrial natriuretic peptide in pseudo-Bartter's syndrome
8. Bartter's syndrome
9. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis
10. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting. A possible consequence of high-dose gentamicin therapy
11. Symptomatic hypomagnesemia associated with gentamicin therapy
12. Gentamicin-induced hypomagnesemia
13. A Bartter-like syndrome from capreomycin, and a similar gentamicin tubulopathy
14. Symptomatic hypomagnesemia associated with gentamicin therapy
15. Symptomatic hypocalcemia and hypomagnesemia due to gentamicin therapy in an 8-year-old girl
16. Hypomagnesemic hypocalcemia with hypokalemia caused by treatment with high-dose gentamicin
17. Gentamicin-induced Bartter-like syndrome
18. Renal failure associated with gentamicin therapy
19. Clinical and pathophysiological aspects of aminoglycoside nephrotoxicity
20. Controlled comparison of amikacin and gentamicin
21. The influence of dosage regimen on experimental gentamicin nephrotoxicity: Dissociation of peak serum levels from renal failure
22. Double-blind comparison of nephrotoxicity and auditory toxicity of gentamicin and tobramycin
23. Studies of risk factors for aminoglycoside nephrotoxicity
24. Effect of potassium depletion on gentamicin nephrotoxicity
25. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats
26. Effect of potassium depletion on ischemic renal failure
27. The pathology, of acute renal failure due to interstitial nephritis in man with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity
28. Effect of aldosterone on the metabolism of magnesium
29. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
30. Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: Dose-response relationship and role of renal tubular injury